VACCINE - The Salt Lake Tribune http://www.sltrib.com/feeds/topics/VACCINE News from The Salt Lake Tribune en-us webmaster@sltrib.com (Webmaster) U.S. to begin safety testing Ebola vaccine next week http://www.sltrib.com/sltrib/world/58347355-68/vaccine-ebola-health-testing.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/world/58347355-68/vaccine-ebola-health-testing.html.csp">U.S. to begin safety testing Ebola vaccine next week</a></h4> <span class="author vcard"><span class="fn">By SETH BORENSTEIN</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-08-28T10:12:20.933-06:00">Updated Aug 28, 2014 10:12AM MDT</span></h5> <div class ="entry-content">Washington • Federal researchers next week will start testing humans with an experimental vaccine to prevent the deadly Ebola virus. The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency’s National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. It will test 20 healthy adult volunteers to see if the virus is safe and triggers an adequate response in their immune systems. Even though NIH has been testing o...</div> <h5><a rel="item-license" href="#license-583473552014-08-28T10:12:20.933-06:00" id="#license-2014-08-28T10:12:20.933-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58347355@www.sltrib.com Thu, 28 Aug 2014 10:12:20 MDT U.N.: Ebola cases could eventually reach 20,000 http://www.sltrib.com/sltrib/world/58347282-68/ebola-outbreak-cases-health.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/world/58347282-68/ebola-outbreak-cases-health.html.csp">U.N.: Ebola cases could eventually reach 20,000</a></h4> <span class="author vcard"><span class="fn">By JOHN HEILPRIN </span></span> <span class="author vcard"><span class="fn">and KRISTA LARSON</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-08-28T19:59:09.033-06:00">Updated Aug 28, 2014 07:59PM MDT</span></h5> <div class ="entry-content">Geneva • The Ebola outbreak in West Africa eventually could exceed 20,000 cases, more than six times as many as are known now, the World Health Organization said Thursday as the United States announced plans to test an experimental Ebola vaccine. Currently, about half of the people infected with Ebola have died, so in a worst-case scenario the death toll could reach 10,000, the agency said, according to a plan released Thursday on how to stop the outbreak. The U.N. agency’s latest figures show ...</div> <h5><a rel="item-license" href="#license-583472822014-08-28T19:59:09.033-06:00" id="#license-2014-08-28T19:59:09.033-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58347282@www.sltrib.com Thu, 28 Aug 2014 19:59:09 MDT NewLink Genetics: Ready to test Ebola vaccine http://www.sltrib.com/sltrib/world/58296646-68/vaccine-ebola-newlink-genetics.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/world/58296646-68/vaccine-ebola-newlink-genetics.html.csp">NewLink Genetics: Ready to test Ebola vaccine</a></h4> <span class="author vcard"><span class="fn">The Associated Press </span></span> <h5><span class="updated" title="2014-08-14T08:57:14.328-06:00">Updated Aug 14, 2014 08:57AM MDT</span></h5> <div class ="entry-content">An Iowa drug developer says it is ready to start an initial round of human testing for a possible vaccine for the deadly Ebola virus. NewLink Genetics Chief Financial Officer Gordon Link said Thursday the timing of the testing, which would involve up to 100 healthy volunteers, is uncertain. “We’re getting a lot of assistance from a number of sources to accelerate this, so exactly how long it’s going to take is a little uncertain because people are greasing the paths as much as they can,” Link sa...</div> <h5><a rel="item-license" href="#license-582966462014-08-14T08:57:14.328-06:00" id="#license-2014-08-14T08:57:14.328-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58296646@www.sltrib.com Thu, 14 Aug 2014 08:57:14 MDT Letter: Sabin vaccine, not Salk, removed polio’s terror http://www.sltrib.com/sltrib/opinion/58292999-82/vaccine-sabin-polio-salk.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/opinion/58292999-82/vaccine-sabin-polio-salk.html.csp">Letter: Sabin vaccine, not Salk, removed polio’s terror</a></h4> <h5><span class="updated" title="2014-08-13T16:12:02.13-06:00">Updated Aug 13, 2014 04:12PM MDT</span></h5> <div class ="entry-content">I’ve always admired George Will for his font of knowledge. But I was dismayed to read this in his column (“Maybe it is not a benevolently ordered universe,” August 12): “The 1950s success of the Salk vaccine in removing the terror of polio had encouraged the belief that pharmacology could slay all infectious diseases.” In fact, the oral vaccine developed in the late 1950s by Albert B. Sabin of the University of Cincinnati has been most successful in preventing the spread of polio worldwide, not...</div> <h5><a rel="item-license" href="http://www.sltrib.com/pages/privacy"> Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58292999@www.sltrib.com Wed, 13 Aug 2014 16:12:02 MDT